LCS commercial launch is ongoing in U.S. following FDA 510(k) clearanceCE-marking regulatory process is on-going with a decision expected in Q2 2026 that could trigger commercial rollout of eyonis® ...

A new study by researchers at Wake Forest University School of Medicine has identified a promising strategy to treat brain ...

Benefits include reduced radiation exposure, fewer adverse reactions, higher image quality, and better detection of malignant features.

Radiation therapy is a cornerstone of lung cancer treatment. But even when delivered with precision, radiation can damage healthy lung tissue. "Try as we might, when we deliver radiation to a cancer, ...

New research warns that popular deep learning systems trained for cancer pathology may be relying on hidden shortcuts rather than genuine biological signals.

As a nonsmoker lung cancer hasn't been a concern of mine, but I recently heard it can affect people who have never smoked. If ...

Patient advocates are calling for the immediate creation of a dedicated PhilHealth Z Benefit Package for lung cancer, warning that the absence of ...

Hernexeos is the second drug to secure an FDA approval under the agency’s priority voucher scheme, following in the footsteps of USAntibiotics’ Augmentin XR, which was granted the ticket in December ...

Malaysia has a new national plan to tackle cancer, tuberculosis, and chronic respiratory conditions in a single approach. Jacqui Thornton reports.

Optellum, the leading AI-enabled solution for earlier lung cancer detection, is thrilled to announce that it has received Therapeutic Goods Administration (TGA) class IIb approval in Australia for the ...